Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Impact of Continuing Medical Education (CME) Insulin Program

This study has been completed.
Sponsor:
Collaborators:
International Diabetes Center at Park Nicollet
Eli Lilly and Company
Novo Nordisk A/S
United Health Care
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Park Nicollet Institute
ClinicalTrials.gov Identifier:
NCT00824603
First received: January 15, 2009
Last updated: August 22, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2009
  Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)